AI-generated image of a robot in a lab coat in a bio lab, holding a clipboard.
AI-generated image of a robot in a lab coat in a bio lab, holding a clipboard.
Generative AI is helping accelerate healthcare through OpenAI’s work with Moderna and Oscar.

The buzz around artificial intelligence has reached every corner of the business world, prompting forward-thinking leaders to ask the critical question: “Who’s actually using AI in their operations?”

Last week, OpenAI answered.

OpenAI interviewed two of their enterprise healthcare clients – Moderna and Oscar – to learn more about how they are leveraging AI to transform how their business.

Moderna Highlights (video here):

  • The legal team boasts a 100% adoption rate of ChatGPT, including for quick review and inquiry of contracts
  • The Clinical Development team uses ChatGPT to distill 1000’s of pages of data into recommendations supported by experimental details and data visualizations
  • They have developed over 400 GPT’s (customized ChatGPT instances) in 2 months
  • CEO of Moderna [noting that they plan to launch 15 products in the next 5 years]: “To do things the old way would take 100,000 people. Today, our company is 6,000 people.”

Oscar Highlights (video here)

  • CEO: “You can translate the messiness of the Real World into a much clearer digitized plan…applying language models maybe isn’t even the hardest part; it’s then to take that solution you found and put it into a workflow to replace an existing workflow system with it and make it useful in the company’s day-to-day”
  • The product team built a claim assistant that will help automate 4,000 tickets/month
  • AI will assist clinicians with accelerating the review of thousands of medical records, which presently take 20 minutes per record to review, and can be upwards of 500 pages.

Two observations from both videos:

  • Both companies operate under stringent data privacy regulations, typical of the healthcare industry. Privacy has been a major question when using commercial AI products – it speaks volumes that they are willing to trust OpenAI with very sensitive data.
  • The primary use of ChatGPT in both companies revolves around data analysis tasks, particularly document review and summarization—a technique known as retrieval-augmented generation (RAG). This approach has been a great solution to assisting with paperwork-heavy workflows.

OpenAI’s ChatGPT enterprise offering is still only 8 months old, so I expect we will be hearing much more from companies using it in the coming months.

If you liked this post and want to get more like it straight to your inbox, please subscribe to the AI For Business newsletter here: https://buttondown.email/AI_For_Business

If you want just the most important AI news for business, stay informed in just 30 minutes a month with the Executive Summary newsletter by AI For Business. Thank you!

#LLM #LLMs #AI #GenAI #GenerativeAI #OpenAI #Moderna #OscarHealth